Crinetics Pharmaceuticals Cash Flow Statement (2017-2026) | CRNX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	26.09M	27.85M	-184.49M	33.62M	42.38M	41.92M	44.99M	45.99M	50.98M	56.46M	-362.77M	66.46M	74.06M	-76.83M	-80.59M	96.77M	115.64M	-130.09M	-122.64M	-249.27M
Share-based Compensation (Quarter)	4.23M	4.55M	5.16M	5.75M	7.13M	7.43M	7.95M	8.10M	10.18M	11.05M	11.62M	13.45M	18.94M	18.15M	18.84M	20.48M	26.12M	22.70M	21.72M	29.68M
Deferred Taxes (Quarter)
Cash from Operations (Quarter)	-19.95M	-25.67M	-22.90M	-13.54M	-27.98M	-38.48M	-35.21M	-40.72M	-45.73M	-41.34M	-40.81M	-52.86M	-47.64M	-62.82M	-66.87M	-88.45M	-85.85M	-110.72M	-92.90M	-124.70M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.09M	-0.07M	-0.19M	-0.32M	-0.20M	0.13M	0.35M	0.53M	0.91M	1.25M	3.58M	3.85M	3.41M	3.51M	4.16M	4.38M	4.71M	3.60M	2.73M	2.22M
Amortization of Deferred Charges (Quarter)															0.76M	0.81M			0.65M	0.70M
Depreciation & Amortization (CF) (Quarter)	0.23M	0.23M	0.23M	0.24M	0.21M	0.25M	0.28M	0.28M	0.28M	0.27M	0.26M	0.47M	0.75M	0.77M	0.79M	0.93M	0.96M	1.01M	0.99M	1.16M
Change in Working Capital
Change in Receivables (Quarter)																				5.09M
Change in Inventory (Quarter)																				0.91M
Change in Accured Expenses (Quarter)	2.17M	0.49M	3.90M	1.53M	6.71M	-1.33M	4.08M	-1.34M	7.42M	4.38M	1.90M	1.31M	5.21M	0.69M	6.12M	-1.36M	12.52M	6.65M	11.18M	-12.06M
Other Working Capital Changes (Quarter)	-0.89M	4.40M	0.36M	-2.49M	-0.74M	2.54M	0.48M	-0.25M	9.74M	-10.30M	5.33M	-0.21M	-3.68M	2.06M	7.80M	6.92M	-8.70M	20.32M	-2.02M	7.02M
Investing Activities
Capital Expenditures (Quarter)	-0.02M	0.42M	0.02M	0.09M	-0.01M	1.30M	-1.38M	0.02M	0.02M	0.39M	0.45M	1.33M	-0.98M	-0.29M	3.78M	0.26M	4.18M	-4.38M	0.33M	0.46M
Change in Acquisitions & Divestments (Quarter)	20.00M	13.96M	0.24M	11.72M	18.90M	56.19M	70.69M	71.44M	91.17M	87.84M	86.68M	101.38M	139.30M	151.15M	183.97M	306.48M	224.03M	382.37M	271.21M	302.89M
Cash from Investing Activities (Quarter)	19.84M	-7.03M	-101.80M	-43.38M	-174.27M	6.82M	36.85M	48.76M	31.44M	-193.30M	-87.31M	0.31M	-53.64M	20.60M	-542.09M	-85.96M	37.95M	164.81M	57.11M	-252.36M
Financing Activities
Other financing activities (Quarter)	0.74M	0.49M	-1.29M	1.78M	1.74M	-3.52M	4.72M		1.12M		-10.73M	10.36M	2.03M	10.68M	-32.88M	4.44M	2.88M	11.70M	-14.58M	9.94M
Cash from Financing Activities (Quarter)	73.30M	15.46M	163.86M	1.78M	118.99M	1.08M	0.12M	0.48M	12.66M	337.88M	40.22M	393.57M	7.52M	57.33M	556.24M	4.44M	7.05M	3.08M	26.04M	389.88M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)	-0.04M	14.98M	162.01M			-0.01M			11.31M	328.96M	29.29M	383.21M		48.30M	543.53M					380.51M
Additional items
Exchange Rate Effect (Quarter)																				-0.01M
Change in Cash (Quarter)	73.19M	-17.23M	39.16M	-55.15M	-83.25M	-30.58M	1.76M	8.52M	-1.64M	103.24M	-87.90M	341.03M	-93.76M	15.11M	-52.72M	-169.98M	-40.84M	57.17M	-9.76M	12.81M
Free Cash Flow (Quarter)	-19.93M	-26.09M	-22.92M	-13.63M	-27.97M	-39.78M	-33.83M	-40.73M	-45.76M	-41.73M	-41.25M	-54.19M	-46.66M	-62.54M	-70.65M	-88.72M	-90.03M	-106.33M	-93.23M	-125.17M
Net Cash Flow (Quarter)	73.19M	-17.23M	39.16M	-55.15M	-83.25M	-30.58M	1.76M	8.52M	-1.64M	103.24M	-87.90M	341.03M	-93.76M	15.11M	-52.72M	-169.98M	-40.84M	57.17M	-9.76M	12.81M

Research Tools

Developers

Crinetics Pharmaceuticals Cash Flow Statement (2017-2026) | CRNX

Research Tools

Developers

Crinetics Pharmaceuticals Cash Flow Statement (2017-2026) | CRNX

Create an account

Sign In

Reset Password